CA Stock MarketDetailed Quotes
BUX Biomark Diagnostics Inc
- 0.250
- 0.0000.00%
15min DelayMarket Closed Sep 30 09:30 ET
22.72MMarket Cap-12500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.250Pre Close0.00Turnover0.31552wk High0.00%Turnover Ratio90.89MShares0.19552wk Low-0.02EPS TTM22.72MFloat Cap1.020Historical HighLossP/E (Static)90.89MShs Float0.025Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-35.71P/B1Lot Size--Div YieldTTM
Biomark Diagnostics Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.61%38.31K | 6.34%163.22K | 0.15%39.81K | 12.62%41.54K | 2.85%42.13K | 10.71%39.75K | 249.38%153.49K | 64.82%39.75K | 86.14%36.89K | 40.96K |
| Operating revenue | -3.61%38.31K | 6.34%163.22K | 0.15%39.81K | 12.62%41.54K | 2.85%42.13K | 10.71%39.75K | 249.38%153.49K | 64.82%39.75K | 86.14%36.89K | --40.96K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 48.31%642.61K | -21.51%1.48M | -25.03%383.56K | 4.87%428.19K | -56.41%234.89K | 1.52%433.3K | 30.31%1.89M | -28.65%511.64K | 53.28%408.3K | 202.85%538.83K |
| Selling and administrative expenses | 114.94%347.24K | -24.71%721.97K | 0.29%190.04K | -43.86%140.86K | -38.15%229.52K | 9.58%161.55K | 69.88%958.96K | -20.53%189.49K | 120.27%250.93K | 250.38%371.12K |
| -General and administrative expense | 114.94%347.24K | -24.71%721.97K | 0.29%190.04K | -43.86%140.86K | -38.15%229.52K | 9.58%161.55K | 69.88%958.96K | -20.53%189.49K | 120.27%250.93K | 250.38%371.12K |
| Research and development costs | 14.09%182.16K | 19.18%650.53K | -20.28%211.29K | 209.15%185.11K | 31.82%94.49K | 6.98%159.65K | 9.66%545.84K | -27.62%265.05K | -9.44%59.88K | 122.70%71.68K |
| Depreciation amortization depletion | -43.66%57.75K | 1.81%393.17K | -1.84%100.85K | 10.04%99.31K | -6.30%90.52K | 6.10%102.5K | 115.00%386.2K | -21.15%102.74K | 104.44%90.25K | 3,635.65%96.6K |
| -Depreciation and amortization | -43.66%57.75K | 1.81%393.17K | -1.84%100.85K | 10.04%99.31K | -6.30%90.52K | 6.10%102.5K | 115.00%386.2K | -21.15%102.74K | 104.44%90.25K | 3,635.65%96.6K |
| Other taxes | ---- | ---193.49K | --0 | --0 | ---193.49K | ---- | --0 | --0 | --0 | --0 |
| Other operating expenses | 478.36%55.47K | -1,599.50%-92.25K | -159.94%-118.62K | -59.74%2.92K | 2,557.45%13.86K | -71.39%9.59K | -102.65%-5.43K | -155.97%-45.63K | -82.80%7.26K | -101.51%-564 |
| Operating profit | -53.55%-604.3K | 23.98%-1.32M | 27.15%-343.76K | -4.10%-386.65K | 61.28%-192.76K | -0.68%-393.55K | -23.45%-1.73M | 31.91%-471.9K | -50.64%-371.42K | -179.83%-497.88K |
| Net non-operating interest income (expenses) | 25.01%-18.98K | -1.05%-111.31K | -60.70%-47.58K | 9.93%-20.07K | 27.07%-21.88K | 10.43%-25.31K | -121.71%-110.15K | 18.51%-29.61K | -130.86%-22.28K | -1,498.72%-30.01K |
| Non-operating interest income | ---- | 4,787.34%3.86K | 308.86%323 | --0 | ---- | ---- | --79 | --79 | --0 | ---- |
| Non-operating interest expense | -25.01%18.98K | 4.48%115.17K | 61.36%47.91K | -9.93%20.07K | -27.07%21.88K | -10.43%25.31K | 121.87%110.23K | -18.29%29.69K | 130.86%22.28K | 1,498.72%30.01K |
| Other net income (expenses) | 638 | 33 | -41 | 646 | ||||||
| Gain on sale of security | ---- | --638 | --33 | ---41 | --646 | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -48.80%-623.28K | 22.52%-1.43M | 21.97%-391.31K | -3.32%-406.76K | 59.46%-214K | 0.07%-418.86K | -26.71%-1.84M | 31.29%-501.51K | -53.26%-393.7K | -195.91%-527.88K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -48.80%-623.28K | 22.52%-1.43M | 21.97%-391.31K | -3.32%-406.76K | 59.46%-214K | 0.07%-418.86K | -26.71%-1.84M | 31.29%-501.51K | -53.26%-393.7K | -195.91%-527.88K |
| Net income continuous operations | -48.80%-623.28K | 22.52%-1.43M | 21.97%-391.31K | -3.32%-406.76K | 59.46%-214K | 0.07%-418.86K | -26.71%-1.84M | 31.29%-501.51K | -53.26%-393.7K | -195.91%-527.88K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -48.80%-623.28K | 22.52%-1.43M | 21.97%-391.31K | -3.32%-406.76K | 60.13%-210.46K | 0.07%-418.86K | -26.71%-1.84M | 31.29%-501.51K | -53.26%-393.7K | -195.91%-527.88K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -48.80%-623.28K | 22.52%-1.43M | 21.97%-391.31K | -3.32%-406.76K | 60.13%-210.46K | 0.07%-418.86K | -26.71%-1.84M | 31.29%-501.51K | -53.26%-393.7K | -195.91%-527.88K |
| Diluted earnings per share | 0.00%-0.02 | 0.00%-0.02 | 0 | 0.00%-0.02 | -100.00%-0.02 | 0.00%-0.02 | 0.00%-0.02 | 0 | -463.06%-0.02 | -305.35%-0.01 |
| Basic earnings per share | 0.00%-0.02 | 0.00%-0.02 | 0 | 0.00%-0.02 | -100.00%-0.02 | 0.00%-0.02 | 0.00%-0.02 | 0 | -463.06%-0.02 | -305.35%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data